Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas
Tanaka, Yuka, Momose, Shuji, Tabayashi, Takayuki, Sawada, Keisuke, Yamashita, Takahisa, Higashi, Morihiro, Sagawa, Morihiko, Tokuhira, Michihide, Rosenwald, Andreas, Kizaki, Masahiro, Tamaru, Jun‐ichiJournal:
Cancer Science
DOI:
10.1111/cas.14286
Date:
January, 2020
File:
PDF, 1.20 MB
2020